Review of state laws for reporting or notification requirements for prenatal substance exposure of newborns to child protective or welfare services Authors: Kodasha Thomas, Dawn Pepin, Charlan D Kroelinger, Richard W Puddy, Shanna Cox Published: 2026 ABSTRACT AbstractIntroduction:Some state laws include language that require reporting or notification of prenatal substance exposure to child protective or welfare services. There is variation in the requirements specified in state laws.Methods:Using a cross-sectional legal epidemiology study design, we examined state laws in the United States (all 50 states and the District of Columbia) as of -December 2020, to identify language describing reporting or notification requirements for prenatal substance exposure of newborns to child protective or welfare services. We assessed whether these state laws included language specific to: Plans of Safe Care, type of provider required to report, and legal penalties for failure to report.Results:Laws in two-thirds of states (37 of 51) included language on reporting or notification requirements for prenatal substance exposure. Among the 37 states with laws that contain language on reporting or notification, 17 included language on Plans of Safe Care; 20 included language on required reporting specific to healthcare workers involved in the prenatal, delivery, or postnatal care of newborns with prenatal substance exposure; and 24 included legal penalties for healthcare worker failure to report.Conclusion:In 2020, most states had laws that included language on reporting and notification requirements for prenatal substance exposure; however, less than half of states with reporting or notification requirements included language on Plans of Safe Care. Documenting the variation in the requirements of these state laws can serve as a baseline to assess changes over time and inform research on studies that assess health and social outcomes.Keywords: Prenatal substance use, Mandated reporting, Provider penalties, Child abuse and neglect law, Substance-exposed newborns, Plans of safe care Introduction Substance use during pregnancy can impact the health outcomes of pregnant women and infants (American College of Obstetrics & Gynecology [ACOG], 2017; Centers for Disease Control & Prevention [CDC], 2025a; Patrick et al., 2020). The 2022 National Survey on Drug Use and Health reported 9.6% of pregnant women had used federally illicit substances in the past month (Substance Abuse & Mental Health Services Administration [SAMHSA], n.d.). Mental health conditions, inclusive of substance use disorders and overdoses, are a leading cause of pregnancy-related deaths (CDC, 2025b). Infants born with prenatal substance exposure are at increased risk of adverse outcomes including preterm birth, low birthweight, extended hospital stays, hospital readmission, and post-neonatal death within the first year following birth (Brown et al., 2025; Grossarth et al., 2023; Hwang et al., 2017). Neonatal abstinence syndrome (NAS) refers to clinical signs of withdrawal that may occur in infants after in utero exposure to opioids and other substances (the more specific term, NOWS, refers to neonatal opioid withdrawal syndrome, or withdrawal from opioid exposure) (CDC, 2025a; Jilani et al., 2022). Incidence of NAS increased from 4.0 per 1000 birth hospitalizations in 2010 to 7.3 per 1000 birth hospitalizations in 2017 and has subsequently declined to 5.3 per 1000 birth hospitalizations in 2022 (Health Resources & Services Administration, n.d.). Clinical organizations including the American College of Obstetrics and Gynecology, American Academy of Pediatrics, and the American Society of Addiction Medicine, and federal agencies such as the Substance Abuse and Mental Health Services Administration offer guidance on screening, treatment, and referral of pregnant and postpartum women with substance use disorder (ACOG, 2017; American Society of Addiction Medicine, 2020; Patrick et al., 2020; SAMHSA, 2018). Overall, these guidelines emphasize an evidence-based, non-stigmatizing, public health approach for substance use disorder intervention among pregnant and parenting women to include increased access to treatment services, and an integrated mother and infant dyad-focused approach to care, with coordinated health and supportive services. Social service agencies, healthcare systems, and healthcare providers can support the development of Plans of Safe Care as part of discharge planning to provide coordination of supportive care and outline services needed for the mother and infant (ACOG, 2017; CDC, 2025a; Patrick et al., 2020; SAMHSA, 2018). A Plan of Safe Care, also called a Family Care Plan in some states (Sieger et al., 2023), is designed to support the mother and infant dyad to address infant safety and well-being and provide access to treatment services for the primary caregiver (Child Welfare Information Gateway, n.d.-a). Plans can be flexible depending on the needs of the family and may include substance use and mental health assessment and services, housing assistance, vocational training, coordination of developmental screenings, early intervention services, or recommendations for home visiting programs (Child Welfare Information Gateway, n.d.-a). A recent study of state laws and statutes concluded inconsistent use and description of plans of safe care including processes for development and implementation (Sieger et al., 2025). Legal context The Child Abuse Prevention and Treatment Act (CAPTA) was originally enacted in 1974 and has been amended and reauthorized periodically (Child Welfare Information Gateway, n.d.-b; CAPTA, 1974). CAPTA provides funding and guidance to states to support efforts to prevent and investigate child abuse and neglect. To qualify for CAPTA funding, a state must have a child abuse and neglect law with provisions for reporting and sufficient services. While CAPTA did not expressly include prenatal substance exposure in how it defined child abuse and neglect for eligibility and implementation of the Act, beginning in the 1970s, and accelerating in the 1980s and 1990s, some states began classifying maternal illicit drug and alcohol use with subsequent prenatal exposure as child abuse or neglect (Lester et al., 2004; Steinberg & Gehshan, 2000). There were several amendments to CAPTA that address prenatal substance exposure. In 2003, the Keeping Children and Families Safe Act amended CAPTA funding eligibility requirements to include “policies and procedures (including appropriate referrals to child protection service systems and other appropriate services) to address the needs of infants born and identified as being affected by illegal substance abuse or withdrawal symptoms resulting from prenatal drug exposure, including a requirement that health care providers involved in the delivery of such infants notify the child protective services system of the occurrence of such condition…” (Keeping Children & Families Safe Act, 2003). Of note, the 2003 Act specified that “such notification shall not be construed to establish a definition under Federal law of what constitutes child abuse” (Keeping Children & Families Safe Act, 2003). In addition, the 2003 Act amended funding eligibility requirements to include “the development of a plan of safe care for the infant born and identified as being affected by illegal substance abuse or withdrawal symptoms” (Keeping Children & Families Safe Act, 2003). The Comprehensive Addiction and Recovery Act of 2016 (CARA) further amended language related to prenatal substance exposure in CAPTA (CARA, 2016). The 2016 Act removed the term ‘illegal’ such that it applied to the development of a Plan of Safe Care for infants identified as being affected by exposure to legal and illegal substances. The 2016 Act includes additional text describing the intent of a Plan of Safe Care i.e., “…to ensure the safety and well-being of such infant following release from the care of healthcare providers, including through (I) addressing the health and substance use disorder treatment needs of the infant and affected family or caregiver; and (II) the development and implementation by the state of monitoring systems” (CARA, 2016). CAPTA was further amended by the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act in 2018 (SUPPORT, 2018). This Act authorized funding for “grants to states for the purpose of assisting child welfare agencies, social services agencies, substance use disorder treatment agencies, hospitals with labor and delivery units, medical staff, public health and mental health agencies, and maternal and child health agencies to facilitate collaboration in developing, updating, implementing, and monitoring plans of safe care…” among other provisions for substance use disorder (SUPPORT, 2018). Previous research has used legal mapping methods to characterize state laws as it relates to prenatal substance exposure, child abuse and neglect reporting and notification, and healthcare provider mandatory reporting; however, there is heterogeneity in approaches and categorizations reported. A systematic content analysis of statutes as of 2015 in all states (inclusive of the District of Columbia (DC), found that 20 states had laws requiring health care providers to report perinatal substance use to child protective authorities, yet among these only 13 had a provision promoting substance use disorder treatment in the perinatal period (Jarlenski et al., 2017). A legal mapping study of state laws from 1974 to 2019 found that 24 states and DC had passed laws classifying prenatal drug use as child abuse or neglect, and 37 states and DC required healthcare provider reporting (or notification) of prenatal substance use to a state agency (McCourt et al., 2022). A legal review found that as of 2022, 25 states had adopted policies that respond to prenatal drug use with legal system penalties (i.e., criminal charges for prenatal drug use, involuntary commitment for pregnant women, or custody-related repercussions) (Bruzelius et al., 2024). Another legal review found as of 2019, 33 states and DC passed laws giving pregnant and postpartum women priority access to public drug treatment programs, yet among these jurisdictions, 82% also had laws deeming prenatal drug use to be child maltreatment, mandating reporting of diagnosed or suspected prenatal drug use to child protective services or criminalizing prenatal drug use (White et al., 2023). Study purpose The objective of this study is to examine state laws (to include statutes, regulations, and case law) to identify those with language describing reporting or notification requirements for prenatal substance exposure of newborns to child protective or welfare services, similar to previously published research. We further reviewed these state laws for inclusion of language related to Plans of Safe Care and health care providers (whether it is specified that all healthcare workers are required to report, if there is specific language related to those involved in prenatal, delivery, or postnatal care of an infant, and whether state laws specified penalties for healthcare worker failure to report). This review examines state laws related to prenatal substance exposure as of December 2020, a point in time after amendments to CAPTA between 2003 and 2018. This study provides a baseline that can be used to track changes over time (e.g. increases in the number of state laws with language inclusive of Plans of Safe Care) and inform the development of models to assess impacts of policies (e.g. association with increased referrals to and delivery of appropriate services to infants and family members affected by substance abuse). Methods Using a cross-sectional legal epidemiology study design, we conducted a legal mapping review of state laws (to include the 50 states and DC) for reporting or notification requirements of prenatal substance exposure to child protective services (or a similar child welfare entity) as of December 2020 (Table 1). We used the legal database WestlawNext to identify state laws that included language relevant to prenatal substance use including child abuse and neglect language (WestlawNext, n.d.). In the circumstance where state statutory or regulatory language on prenatal substance exposure was ambiguous or unclear to our legal expert, we also conducted a review of caselaw for those state laws. Next, we determined whether statutory or regulatory language was included within child abuse and neglect law or other laws and grouped states in two categories: child abuse and neglect law or other laws, noting differences or exceptions in language. Then we determined whether identified state laws included language with reporting or notification requirements. Table 1Definitions of study variables for legal epidemiology review of state laws.VariableLanguage usedDefinitionChild Abuse and NeglectChild Abuse and NeglectCan include physical harm, endangerment, maltreatment, exposure to chemicals or substances, or other harms as defined by language in state laws. State statutes and regulations may use these terms synonymously or may define abuse and neglect separately.Prenatal Substance ExposurePrenatal Substance ExposureProvisions relevant to neonatal abstinence syndrome; newborns with substance withdrawal symptoms; substance or drug affected infants; positive toxicology tests for the newborn; maternal substance or drug use; or positive toxicology for the mother; as defined in state laws.State Laws: Statutes, Regulations, and Case Law for Required Reporting of Prenatal Substance ExposureState LawsStatutes, regulations, and in some instances, case law, with reporting or notification requirements of prenatal substance or drug exposure to child protective services (or a similar entity) in the state in 2020.Legal Requirements for Reporting or Notification of Child Abuse or Neglect in State LawReporting or Notification RequirementsRequirements of healthcare workers may vary depending on legal mechanism for reporting or notification. State laws may require reporting of prenatal substance or drug exposure to child protective services or another child welfare agency or may only require notification be provided to these agencies. Reporting refers to a legal requirement to report to the state which will result in the initiation of a child protective services investigation. Notification, by contrast, aligns with CAPTA's notification requirement; while it may also require reaching out to state child protective services or another child welfare agency, the explicit goal is connecting the family to services or a plan of safe care without the case being treated as abuse or neglect. Required reporting or notification may be present in language within statute or case law.Plan of Safe Care or Provision of Additional ServicesPlan of Safe CareA plan to ensure that substance exposed infants and caregivers receive necessary treatment and referral for substance use services. This can include substance use services, educational support, and other family supports as defined in state laws.Healthcare Workers Involved in the Prenatal Care, Delivery, or Postnatal CareHealthcare Workers Involved in the Prenatal Care, Delivery, or Postnatal CareLanguage in state laws specifically requiring healthcare workers involved in prenatal care, delivery, or postnatal care to make a report or notification of prenatal substance or drug exposure to child protective services or another child welfare agency.Penalty for Healthcare Worker Failure to ReportPenalties for Failure to ReportExplicit legal penalties for healthcare worker failure to report or notify child protective services or child welfare agencies of child abuse and neglect as defined in state laws. Definitions of study variables for legal epidemiology review of state laws. Among states that had reporting or notification requirements, we identified whether there was additional language for the development of a Plan of Safe Care (to include provision of additional support services such as substance use services, educational support, or other family supports). We also examined whether state laws included language specifying that all healthcare workers are required to report, as well as if the state law was specific to healthcare workers involved in prenatal, delivery, or postnatal care of an infant. Finally, we reviewed whether state laws specified penalties for healthcare worker failure to report (Appendix 1). A lawyer trained in legal epidemiological methods collected, analyzed, and categorized language in all laws. After the initial legal coding was complete, all authors discussed coding discrepancies, refined coding definitions, and resolved minor discrepancies through consensus discussion with additional detail provided by statutory or regulatory language, or case law as appropriate. Descriptive counts were reported to summarize coded information. The study did not require Institutional Review Board approval by the Centers for Disease Control and Prevention (CDC), as it did not include human subjects and utilized publicly available, web-based information. Results In 2020, among all states, 73% (37/51) had state laws with reporting or notification requirements for prenatal substance exposure to child protective services (or a similar child welfare entity) (Table 2). Of those 37 states with reporting or notification requirements, 70% (26/37) included language within their child abuse and neglect laws. For the other 11 states, prenatal substance exposure was not explicitly included within the state definition of child abuse or neglect. Specifically, reporting was only required under some circumstances, or prenatal substance exposure was not considered to be abuse or neglect without additional factors being present (Table 2). Table 2State laws requiring reporting or notification of prenatal substance exposure, if that requirement falls within the definition of child abuse or neglect state law, and if the law includes language on a plan of safe care and services, 50 states and the District of Columbia, 2020.StatesCriteriaState laws forrequired reportingor notification ofprenatal substanceexposureaRequirement fallswithin the definitionof child abuse orneglect in state lawbPlan of safe careor provision ofadditionalservicescAlabamaYesYesNoAlaskaYesdYesNoArizonaYesYesNoArkansasYesYesYesCaliforniaYesNoYesColoradoYesYesNoConnecticutYesdYesYesDelawareYesdYesYesDistrict of ColumbiaYesYesNoFloridaYesYesNoGeorgiaYesYesNoHawaii–e––Idaho–––IllinoisYesYesNoIndianaYesYesNoIowaYesYesNoKansasYesYesNoKentuckyYesNofNoLouisianaYesYesYesMaineYesdYesYesMarylandYesNoYesMassachusettsYesYesNoMichiganYesNoNoMinnesotaYesYesYesMississippi–––MissouriYesNogYesMontanaYesNoNoNebraska–––NevadaYesNoYesNew Hampshire–––New JerseyYesNoYesNew MexicoYesdYesYesNew York–––North Carolina–––North DakotaYesYesYesOhio–––OklahomaYesNoYesOregon–––PennsylvaniaYesdYesYesRhode IslandYesNoNoSouth CarolinaYesYesNoSouth DakotaYesYesNoTennessee–––TexasYesYesNoUtahYesYesNoVermont–––VirginiaYesNoYesWashington–––West Virginia–––WisconsinYesYesYesWyoming–––aState laws: statutes, regulations, and case law with reporting or notification requirements of prenatal substance exposure to child protective services (or a similar entity) in the state in 2020.b“Requirement Falls Within the Definition of Child Abuse or Neglect in State Law” is defined as a ‘yes’ when prenatal substance exposure is within the definition of child abuse or neglect in state law. It is defined as ‘no’ when prenatal substance exposure is not explicitly within the state definition of abuse or neglect nor is the requirement for notification purposes only. While reporting is required under some circumstances, exposure is not considered to be abuse or neglect or not considered abuse or neglect without additional factors being present. In four states (AR, IA, LA, and UT), under certain circumstances prenatal substance exposure is both within the definition of child abuse or neglect in state law and there is a separate requirement for healthcare workers to report. For example, AR has a separate requirement for providers to report both illegal and legal substances for the development of a safe plan of care.c“Plan of Safe Care or Provision of Additional Services” is defined as ‘yes’ when there is a requirement after the report or notification for the development of a Plan of Safe Care or the provision of other services including substance use services, educational support, and other family supports. It is defined as ‘no’ when there is no reference in the reporting provisions to the development of a Safe Plan of Care or the provision of additional services. However, in Louisiana, Plan of Safe Care language is specific to lawful use only. La. Stat. Ann. § 40:1086.11.dDenotes a state that required prenatal substance exposure notification only.eDashes in this table represent states that had no state-level legal requirement for reporting or notification of prenatal substance exposure. No further legal epidemiologic review or analysis was completed on states without legal requirements.fThis requirement sits within a Public Health section of the state statute and specifies that “an infant affected by substance abuse withdrawal symptoms resulting from prenatal drug exposure or fetal alcohol spectrum disorder shall be reported to the state's child protective services agency in accordance with 42 U.S.C. sec. 5106a.” Ky. Rev. Stat. Ann. § 214.160(5).gThis requirement is within a section on Prenatal and Postnatal Care and Education for Women and Children and not child abuse or neglect. However, “nothing in this section shall preclude a physician or other mandated reporter from reporting abuse or neglect of a child as required pursuant to the provisions of Mo. Rev. Stat. Ann. § 210.115.” Mo. Rev. Stat. Ann. § 191.737. State laws requiring reporting or notification of prenatal substance exposure, if that requirement falls within the definition of child abuse or neglect state law, and if the law includes language on a plan of safe care and services, 50 states and the District of Columbia, 2020. State laws: statutes, regulations, and case law with reporting or notification requirements of prenatal substance exposure to child protective services (or a similar entity) in the state in 2020. “Requirement Falls Within the Definition of Child Abuse or Neglect in State Law” is defined as a ‘yes’ when prenatal substance exposure is within the definition of child abuse or neglect in state law. It is defined as ‘no’ when prenatal substance exposure is not explicitly within the state definition of abuse or neglect nor is the requirement for notification purposes only. While reporting is required under some circumstances, exposure is not considered to be abuse or neglect or not considered abuse or neglect without additional factors being present. In four states (AR, IA, LA, and UT), under certain circumstances prenatal substance exposure is both within the definition of child abuse or neglect in state law and there is a separate requirement for healthcare workers to report. For example, AR has a separate requirement for providers to report both illegal and legal substances for the development of a safe plan of care. “Plan of Safe Care or Provision of Additional Services” is defined as ‘yes’ when there is a requirement after the report or notification for the development of a Plan of Safe Care or the provision of other services including substance use services, educational support, and other family supports. It is defined as ‘no’ when there is no reference in the reporting provisions to the development of a Safe Plan of Care or the provision of additional services. However, in Louisiana, Plan of Safe Care language is specific to lawful use only. La. Stat. Ann. § 40:1086.11. Denotes a state that required prenatal substance exposure notification only. Dashes in this table represent states that had no state-level legal requirement for reporting or notification of prenatal substance exposure. No further legal epidemiologic review or analysis was completed on states without legal requirements. This requirement sits within a Public Health section of the state statute and specifies that “an infant affected by substance abuse withdrawal symptoms resulting from prenatal drug exposure or fetal alcohol spectrum disorder shall be reported to the state's child protective services agency in accordance with 42 U.S.C. sec. 5106a.” Ky. Rev. Stat. Ann. § 214.160(5). This requirement is within a section on Prenatal and Postnatal Care and Education for Women and Children and not child abuse or neglect. However, “nothing in this section shall preclude a physician or other mandated reporter from reporting abuse or neglect of a child as required pursuant to the provisions of Mo. Rev. Stat. Ann. § 210.115.” Mo. Rev. Stat. Ann. § 191.737. Of those 37 states with reporting or notification requirements, 46% (17/37) included language to develop a Plan of Safe Care (Table 2). Of the 37 states with reporting or notification requirements, 65% (24/37) required all healthcare workers to report prenatal substance exposure (Table 3). Fifty-four percent (20/37) of states with reporting or notification requirements had language specifically requiring healthcare workers involved in the prenatal care, delivery, or postnatal care of an infant with prenatal substance exposure to report. Of the 37 states with reporting or notification requirements, 65% (24/37) had clearly identified penalties for failure to report prenatal substance exposure. The remaining 13 of 37 states either did not have penalties for failure to report or the language was unclear related to penalties for failure to report. Table 3State laws with language requiring reporting or notification of prenatal substance exposure by all healthcare workers, healthcare workers involved in the prenatal care, delivery, or postnatal care, and penalties for healthcare worker failure to report prenatal exposure to substances, 37 states including the District of Columbia, 2020a.StatesCriteriaAllhealthcareworkersHealthcare workersinvolved in the prenatalcare, delivery, orpostnatal carebPenalty forhealthcare workerfailure to reportcAlabamaYes–dYesAlaska–Yes–Arizona–YesYesArkansasYesYesYesCaliforniaYes––ColoradoYes–YesConnecticut–Yes–Delaware–Yes–District of ColumbiaYes–YesFloridaYes–YesGeorgiaYes–YesIllinoisYes–YesIndianaYes–YesIowaYesYesYesKansasYes–YesKentucky–Yes–LouisianaYes–YesMaine–Yes–Maryland–Yes–MassachusettsYes–YesMichiganYes––MinnesotaYes–YesMissouriYes––Montana–Yes–Nevada–YesYesNew JerseyYes––New Mexico–Yes–North DakotaYesYesYesOklahomaYesYesYesPennsylvania–Yes–Rhode Island–YesYesSouth CarolinaYes–YesSouth DakotaYesYesYesTexasYes–YesUtahYesYesYesVirginia–YesYesWisconsinYesYesYesaThis table includes 37 states with laws requiring healthcare workers to report or notify prenatal substance exposure to child protective services (or a similar entity) in the state in 2020. Fourteen states had no identifiable reporting or notification requirements and were therefore excluded from further analysis (i.e., HI, ID, MS, NE, NH, NY, NC, OH, OR, TN, VT, WA, WV, WY).bCertain states have laws including language specifically requiring those healthcare workers involved in prenatal care, delivery, or postnatal care to report or otherwise notify child protective services (or a similar child welfare entity) of prenatal substance exposure.cOf the states with reporting or notification requirements, four (AR, IA, LA, OK) had penalties if the health care worker failed to report or notify only when the exposure was considered abuse or neglect.dDashes in all columns represent state laws that do not include language specific to each criterion. A dash in the ‘All Healthcare Workers’ column indicates that state law does not refer to all healthcare workers. A dash in the ‘Healthcare Workers Involved in the Prenatal Care, Delivery, or Postnatal Care’ column indicates that this type of healthcare worker is not specified in state law. A dash in the ‘Penalty for Healthcare Worker Failure to Report’ column indicates that the state law does not include language on reporting penalties for healthcare workers. State laws with language requiring reporting or notification of prenatal substance exposure by all healthcare workers, healthcare workers involved in the prenatal care, delivery, or postnatal care, and penalties for healthcare worker failure to report prenatal exposure to substances, 37 states including the District of Columbia, 2020a. This table includes 37 states with laws requiring healthcare workers to report or notify prenatal substance exposure to child protective services (or a similar entity) in the state in 2020. Fourteen states had no identifiable reporting or notification requirements and were therefore excluded from further analysis (i.e., HI, ID, MS, NE, NH, NY, NC, OH, OR, TN, VT, WA, WV, WY). Certain states have laws including language specifically requiring those healthcare workers involved in prenatal care, delivery, or postnatal care to report or otherwise notify child protective services (or a similar child welfare entity) of prenatal substance exposure. Of the states with reporting or notification requirements, four (AR, IA, LA, OK) had penalties if the health care worker failed to report or notify only when the exposure was considered abuse or neglect. Dashes in all columns represent state laws that do not include language specific to each criterion. A dash in the ‘All Healthcare Workers’ column indicates that state law does not refer to all healthcare workers. A dash in the ‘Healthcare Workers Involved in the Prenatal Care, Delivery, or Postnatal Care’ column indicates that this type of healthcare worker is not specified in state law. A dash in the ‘Penalty for Healthcare Worker Failure to Report’ column indicates that the state law does not include language on reporting penalties for healthcare workers. A Sankey Diagram is a visualization tool used to display the relationship among groups, including similarities and differences in the flow of data, as described in the results (Fig. 1). Each pathway directly corresponds to data presented in Tables 2 and 3. Flow Diagram to Visualize State Law Requirements for Reporting or Notification of Prenatal Drug Exposure: Whether Language is Included Within Child Abuse or Neglect Law, Language Includes Plans of Safe Care, and Language Includes Penalties for Healthcare Worker Failure to Report, 2020 (N = 37). Key: The first vertical bar includes all states with language in state law requiring reporting or notification of prenatal drug exposure. Data flow into the second vertical bar in two groups: state laws that include reporting or notification language within Child Abuse or Neglect Law (n = 26); state laws that do not include reporting or notification language within Child Abuse or Neglect Law (n = 11). Data flow into the third vertical bar into two additional groups: state laws that include language on plans of safe care (POSC; n = 17) and included reporting or notification language within Child Abuse or Neglect Law (n = 10) or did not include reporting or notification language within Child Abuse or Neglect state law (n = 7); and state laws that do not include language on POSC (n = 20) and included reporting or notification language within Child Abuse or Neglect Law (n = 16) or did not include reporting or notification language within Child Abuse or Neglect state law (n = 4). Data flow into the final vertical bar where eight groups combine into two additional groups: state laws that include penalties for healthcare worker failure to report (n = 24); and state laws that do not include penalties for failure to report (n = 13). The flow chart depicts how the data interact between the study variables and individual states allowing the reader to visualize the data from Tables 2 and 3 and observe patterns not necessarily visible when reviewing the data counts alone (e.g., the count and flow of state laws that include language on reporting requirements within Child Abuse or Neglect Law [n = 26], do not include language on POSC [n = 16], and include language on penalties for healthcare worker failure to report [n = 15]). Discussion Our review identified almost three quarters of all states had reporting or notification requirements for prenatal substance exposure to child protective services (or a similar child welfare entity) as of December 2020. Upon further review of these state laws, less than half included language on development of a Plan of Safe Care. Almost two-thirds of states with reporting or notification requirements specified reporting for all healthcare workers, and over half had specific language requiring reporting for healthcare workers involved in the prenatal, delivery, or postnatal care of an infant with prenatal substance exposure. Almost two-thirds of states with reporting or notification requirements specified penalties for healthcare worker failure to report. CAPTA was amended between 2003 and 2018 to address prenatal substance exposure and included provisions for eligibility of funding related to notification of child protective service agencies by healthcare providers and the development of Plans of Safe Care; however, it is not required that these aspects be addressed via state law or statute and may be addressed by programs and policies (U.S. Government Accountability Office, 2018). This analysis does not assess other ways states may have institutionalized CAPTA funding eligibility requirements (e.g., surveillance system reporting), nor does our study assess the implementation and enforcement of state laws or statutes. Yet, state laws and statutes can facilitate public health goals (Moulton et al., 2009). Evaluations of the impacts of public health law are facilitated by the availability of coded statutory data sets which account for variation in the structure of state laws (Burris et al., 2016; Costich, 2012). The variation in the structure of state laws allows for “natural experiment” statistical methods to assess causal inference (Wagenaar & Komro, 2023). Notably, the CARA amended the annual data reporting requirements in CAPTA to include the number of infants identified as being affected by substance abuse or withdrawal symptoms, the number of such infants for whom a plan of safe care was developed, and the number of such infants for whom a referral was made for appropriate services, including services for the affected family or caregiver (CARA, 2016). Researchers can combine the information in this legal review and jurisdictional requirements for Plans of Safe Care or Family Care Plans with outcomes of interest such as referral for early intervention services for infants affected by prenatal substance exposure or receipt of appropriate services for caregivers with substance use disorders, to conduct multi-state evaluations. Researchers can use this study to examine outcomes among infants referred to child welfare agencies in states that have mandatory reporting laws compared with states that have notification requirements (Sieger, Nichols, Chen, et al., 2022). This review of state laws provides a point in time description of reporting requirements in the immediate period after amendments to CAPTA related to prenatal substance exposure that can serve as a baseline to assess changes over time and inform research for studies that assess health and social outcomes (Sieger et al., 2025; Sieger, Nichols, & Chasnoff, 2022). Our results demonstrate differences in state laws with reporting or notification requirements for prenatal substance exposure to child protective services and requirements of healthcare providers. Healthcare providers are a key audience for the implementation of evidence-based recommendations to standardize and improve the quality of health care services for pregnant and postpartum women with substance use disorder (Krans et al., 2019). Previous research has described healthcare provider challenges with state laws with reporting or notification requirements to include confidentiality and care concerns (Madora et al., 2022; Nguemeni Tiako & Sweeney, 2022). Studies have found that women who use substances during pregnancy in states with child abuse or mandatory reporting polices for prenatal substance exposure are less likely to receive evidence-based care which can result in lower rates of receipt of medication for opioid use disorder (Bruzelius et al., 2024; Syvertsen et al., 2021) or substance use treatment program admissions (Atkins & Durrance, 2020; Bruzelius et al., 2024; Kozhimannil et al., 2019; Syvertsen et al., 2021), avoidance or delay in prenatal care (Austin et al., 2022; Bruzelius et al., 2024), and decreased attendance in postpartum healthcare visits (Austin et al., 2022). In the context of a complex clinical practice environment, state-based initiatives may support healthcare providers in the delivery of evidence-based care for pregnant and postpartum women with substance use disorders and infants with prenatal substance exposure. For example, Perinatal Quality Collaboratives have demonstrated effectiveness in improving provider capacity and care outcomes for pregnant and postpartum women with opioid use disorder and infants with NAS (Ellick et al., 2024; Lee King et al., 2020). Multi-sector state leadership teams have implemented action plans to improve maternal and infant outcomes associated with opioid use disorder (OUD) during the perinatal period taking into account ethical, legal, and social considerations (Kroelinger et al., 2020). A common focus area of these initiatives is provider awareness and training activities to include resources and education for providers on screening, treatment and referral protocols and guidelines, clinical or social service resources, and relevant state-specific laws and policies (e.g., mandatory reporting and Plans of Safe Care) (Kroelinger et al., 2020). In an implementation evaluation of statewide activities focused on addressing OUD and NAS, strategies for sustainment included provision of ongoing provider training for substance use screening, support of best clinical practices, provision of trauma-informed care, and implementation of family-based services (Kroelinger et al., 2023). Amendments to CAPTA emphasize Plans of Safe Care for the well-being and safety of infants, support and access to substance use disorder services for families and caregivers, and state monitoring and data reporting (CARA, 2016; Keeping Children & Families Safe Act, 2003; SUPPORT, 2018). In our review, less than half of state laws with reporting or notification requirements for prenatal substance exposure to child protective services or another child welfare agency included language on Plans of Safe Care. However, states can have policies and programs about Plans of Safe Care outside of laws and legal statutes (U.S. Government Accountability Office, 2018; Sieger, Nichols, Chen, et al., 2022), and policy language may vary (Sieger et al., 2025). Additional review of administrative rules, manuals, or annual progress and services reports can provide researchers with Plans of Safe Care details, information, and requirements, though may vary in public availability (Sieger et al., 2025). Also, awareness of state laws related to Plans of Safe Care may serve as a lever for multidisciplinary and multiagency collaboration. For example, a multidisciplinary statewide quality improvement initiative in Missouri demonstrated an increase in Plans of Safe Care at hospital discharge for infants and mothers (Spence & Williams, 2024). Limitations Our study has several limitations. This analysis cannot draw conclusions related to health or social outcomes associated with these laws. This was a cross-sectional study of state laws in 2020; since this time laws may have been implemented or amended and thereby categorized differently. Differences between counts reported in this study and prior legal studies of child welfare laws on prenatal substance use may be due to differences in definitions used and different interpretations of the legal language between states. Our legal mapping study analyzes laws for the year 2020 (previously published studies looked at earlier years) in a manner that can serve as a baseline to track changes over time and may be used to inform future studies related to outcomes. We limited our review to the plain language of the law (i.e., statutes, regulations, and targeted caselaw review where we determined the meaning to be ambiguous or unclear). The broader body of caselaw, as well as state policies, local laws, and the interpretations and discretion used in practice are not captured in this review. Though we noted differences in state mandatory reporting and required notification, we did not review administrative rules which could include language on implementing plans of safe care beyond what is defined in law or statute. The findings from this study would not be useful for a causal inference analysis as it did not include review of enactment dates for all state laws and statutes, nor does it assess impact on maternal or infant outcomes. Conclusions Reporting or notification requirements for prenatal substance exposure to child protective services or another child welfare agency varies across the United States. Healthcare providers may benefit from training and resources to support awareness and application of state laws. Study results provide a baseline for additional research which could examine long-term effects of state laws on evidence-based public health programs and practices. Our legal mapping study may support future legal epidemiological research that explores the impact of variations in these laws, on clinical practice related to mandatory reporting requirements, health seeking behaviors of patients, and health and social outcomes for the mother and infant dyad. Supplementary Material Acknowledgements The authors would like to acknowledge the participation in discussions, formatting, and general support provided by the following fellows on this legal epidemiology review: Shivani Shah, Madison Levecke, and Kecia Ellick. The authors would also like to acknowledge the review of a subject matter expert, Jean Ko. Funding statement The author(s) received no financial support for the research, authorship, and/or publication of this article. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention. List of abbreviations Neonatal Abstinence Syndrome Neonatal Opioid Withdrawal Syndrome Child Abuse and Prevention Treatment Act Comprehensive Addiction and Recovery Act of 2016 (SUPPORT) for Patients and Communities Act in 2018 Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment District of Columbia Opioid Use Disorder Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi.org/10.1016/j.josat.2026.210112. Footnotes CRediT authorship contribution statement Kodasha Thomas: Writing – review & editing, Project administration, Data curation. Dawn Pepin: Writing – original draft, Validation, Resources, Investigation, Formal analysis, Data curation, Conceptualization. Charlan D. Kroelinger: Writing – review & editing, Visualization, Supervision, Project administration, Formal analysis, Conceptualization. Richard W. Puddy: Writing – review & editing, Supervision, Methodology, Conceptualization. Shanna Cox: Writing – review & editing, Methodology, Formal analysis, Conceptualization. Ethical approval and consent to participate The study did not require Institutional Review Board approval by the Centers for Disease Control and Prevention (CDC), as it did not include human subjects and utilized publicly available, web-based information. Declaration of competing interest The author(s) declare that they have no competing interests. Data availability All data generated and analyzed for this study are available in Appendix 1. References Associated Data Supplementary Materials Data Availability Statement All data generated and analyzed for this study are available in Appendix 1.